Ibuprofen Stada

Ibuprofen, the active ingredient in Ibuprofen Stada, is a nonsteroidal anti-inflammatory drug (NSAID) presented as a strength/form for oral use. It treats mild to moderate pain, fever, and inflammatory conditions such as arthritis in adults.

GNH USA supplies Ibuprofen Stada as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen acts on inflammatory pathways to relieve symptoms in several common conditions.

Mild to moderate pain: provides analgesic relief for headaches, dental pain, musculoskeletal discomfort. Fever: reduces elevated body temperature associated with infections or inflammatory states. Arthritis: decreases joint inflammation and pain in osteoarthritis and rheumatoid arthritis.

Adverse reactions may occur with ibuprofen use and vary in frequency and severity.

Common Side Effects: - Gastrointestinal discomfort or dyspepsia - Nausea or vomiting - Headache - Dizziness - Mild skin rash - Elevated blood pressure

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding - Acute renal impairment or failure - Severe hypersensitivity reactions (e.g., anaphylaxis, Stevens‑Johnson syndrome) - Hepatotoxicity with elevated liver enzymes - Cardiovascular events such as myocardial infarction or stroke - Thrombocytopenia or other blood dyscrasias

Before initiating therapy, consider the following safety measures.

Assess gastrointestinal risk: evaluate history of ulcer disease or bleeding. Monitor renal function: avoid in patients with severe renal impairment. Avoid in known hypersensitivity: do not use if the patient is allergic to ibuprofen or other NSAIDs. Use lowest effective dose: limit duration to the shortest period needed for symptom control. Store at below 25°C: keep in the original pack, protect from moisture.

Ibuprofen can affect the pharmacokinetics or pharmacodynamics of several medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Selective COX‑2 inhibitors: additive gastrointestinal toxicity. - Lithium: ibuprofen may raise serum lithium levels.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in renal function. - Diuretics: enhanced risk of nephrotoxicity. - Methotrexate: decreased clearance leading to toxicity.